Excited for this to be finally out! Pre-computed lists of SNVs with evidence of pathogenicity are available at figshare.com/s/a8ed691e7985a… and the Tocayo pipeline is available at github.com/cassalab/tocayo.
Are clinical labs underusing the ACMG/AMP prior variant classification criteria when assessing SNVs? Meet Tocayo: a pipeline for analyzing SNVs with evidence of pathogenicity according to PS1, PM5 & PVS1 criteria @cassalabbwh @ccassa @vbhat47 @James_D_Fife https://xitter.gq/t.co/0bN0pHE7m0
Vineel Bhat retweeted
Excited to share a project led by Vineel Bhat @vbhat47 which identifies that 4.6% of VUSs within #ClinVar have supporting evidence of pathogenicity when following the ACMG/AMP SVI guidelines @TheACMG @AMPath @NCBI_Clinical medrxiv.org/content/10.1101/…



